Viewing Study NCT01728259


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2026-01-31 @ 2:00 AM
Study NCT ID: NCT01728259
Status: TERMINATED
Last Update Posted: 2023-05-09
First Post: 2012-11-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Light Chain Deposition Disease View
None Primary Systemic Amyloidosis View
Keywords: